RT @paomorejon: 📌FA de novo en pacientes críticos •Marcador de severidad •Asociación con☠️es incierta •Asociación con☠️ en el subgrupo de…
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
New-onset #atrial #fibrillation and associated outcomes and resource use among #critically #ill adults-a multicenter retrospective cohort study. #CriticalCare #CriticalIll #ICU https://t.co/oqbOzDQSSx https://t.co/joLelnsV3w
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
RT @paomorejon: 📌FA de novo en pacientes críticos •Marcador de severidad •Asociación con☠️es incierta •Asociación con☠️ en el subgrupo de…
RT @MortenHylander: Common, costly and associated with adverse outcome #NOAF Unanswered questions: 👉 What is the better treatment option…
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults-a multicenter retrospective cohort study. https://t.co/jRbQVzB7av
RT @paomorejon: 📌FA de novo en pacientes críticos •Marcador de severidad •Asociación con☠️es incierta •Asociación con☠️ en el subgrupo de…
RT @paomorejon: 📌FA de novo en pacientes críticos •Marcador de severidad •Asociación con☠️es incierta •Asociación con☠️ en el subgrupo de…
RT @MortenHylander: Common, costly and associated with adverse outcome #NOAF Unanswered questions: 👉 What is the better treatment option…
RT @paomorejon: 📌FA de novo en pacientes críticos •Marcador de severidad •Asociación con☠️es incierta •Asociación con☠️ en el subgrupo de…
📌FA de novo en pacientes críticos •Marcador de severidad •Asociación con☠️es incierta •Asociación con☠️ en el subgrupo de sepsis •Mayor tiempo de internación en UCI y mayor costos💵 ⚠️Si no revierte 24 hs post-tratamiento https://t.co/E8OHdxZzWw #Critical
RT @MortenHylander: Common, costly and associated with adverse outcome #NOAF Unanswered questions: 👉 What is the better treatment option…
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
Our latest...
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
RT @shanfernands: New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortal…
RT @kwadwo777: #RON at it again! Great job @shanfernands and company!
#RON at it again! Great job @shanfernands and company!
New-onset AF (NOAF) is commonly seen in ICU patients. Our @Crit_Care study found that: -NOAF is associated with ↑ mortality in some populations (e.g. sepsis) more so than others; -NOAF is associated with ↑ ICU LOS and costs in all populations. https://t.